The Inflation Reduction Act's drug price controls may be popular. But by discouraging companies from investing in innovative, accessible drugs, they'll harm current and future patients in need of effective therapies.
Subscribe to:
Post Comments (Atom)
< + > Connected Care and Lessons Learned from Consumer Trends in Retail Can Help Clinicians Meet Patient Expectations
The following is a guest article by Lucienne Ide , MD, PhD, Founder and CEO at Rimidi The retail industry’s longstanding commitment to mee...
No comments:
Post a Comment